CEO: Lonnel Coats

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: US

Description: Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include XERMELO, Zynquista, and LX9211. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.


Key numbers

Market Capitalization:186127800
Shares Outstanding: 106970000
Float: 103150850
Next Earning Date:2020-11-05
TTm EPS: 0.8044
TTm Dividend Rate:
200 days moving average:2.81
50 days moving average: 1.95
One day percent Change: 3.16



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,